Medical equipment maker Teleflex Inc. said Monday that it has named Thomas Powell as chief financial officer, succeeding Richard Meier.
Medical device maker said it will pay at least $150 million to acquire Cameron Health Inc., maker of a minimally-invasive heart defibrillator.
Driving the move is a wave of computer technology, including touch-screen kiosks found in pharmacies, designed to help patients self-diagnose common diseases.
Community Catalyst alleges increasingly common couponing programs appear to save patients money but violate federal bribery laws.
Cheng Yi Liang pleaded guilty to using a confidential drug database to buy stock in various companies, which earned him nearly $3.8 million.
The FDA is requiring additional study data on the compound, which combines Lipitor, the top-selling drug of all time, with Merck's cholesterol medicine Zetia.
Medical firm and former execs convicted of running unauthorized clinical tests of bone cement are blamed for contributing to the deaths of two elderly women.
The South Korean electronics giant is branching out and is developing new drugs in cooperation with two American biotech firms.
Counterfeit versions of the popular cancer drug Avastin are completely ineffective, but would not likely have a dramatic effect on survival odds.
The company says its earnings picture was "mixed," and gave a cautious outlook for 2012 given "an economic situation marked by uncertainty."
Blisters of pills, made by the Indian company, were rotated so they were not in the proper sequence, which could make them ineffective.
For nearly a century, scientists have struggled to make a diet pill that helps people lose weight without side effects, like heart palpitations and birth defects.
The consumer products maker said the global cuts are part of a restructuring plan to save $10 billion by the end of the fiscal year ending in June 2016.
Experts agree new weight loss drugs are needed to treat an estimated 75 million obese adults in the U.S., but the FDA had thought some were not safe enough.
Regulators said they've approved new suppliers for two crucial cancer drugs, but there are currently 283 other separate drugs in short supply.
The new infant bottle comes with a plastic syringe that's to be inserted into a flow restrictor for the correct dosage, but the restrictor often falls into the bottle.
The FDA had previously rejected the pill for potential heart problems and birth defects in women who become pregnant while taking the drug.
The multibillion-dollar trade has largely been relegated to poor countries with lax regulations, but officials worry more counterfeits will be smuggled into America.
Johnson and Johnson is becoming notorious for a long string of recalls and poor production practices, which leaves me wondering: How have they managed to avoid any genuine outcry?
Doctors are panicking because methotexate is the key treatment for a common childhood cancer called acute lymphoblastic leukemia, and can cure 90 percent of cases.
Federal health officials say Accurate Set has been legally barred from making and selling a variety of dental products due to violations at its manufacturing facility.
Health industry workers worry India may bow to EU demands for strict IP protections, which would close down the supply of medicines to the world's poorest.
The recent decline of venture financing is threatening innovation in the $300 billion global market for medical devices.
Wisconsin-based MRPC, a single-source provider of medical device components and assemblies, has completed construction of a new cleanroom for the molding of medical components.